2008•PubMedRequires access

[A case of successful combination therapy with trans-arterial embolization, trans-arterial chemotherapy and radiofrequency ablation therapy].

Hideo Ôta, Taku Yasumoto, Kazuyuki Okada, Yoshihito Ide, Kentaro Maruyama, Hideoki Yokouchi, Koji Mikami, Masakatsu Kinuta, Kohei Murata

Open publisher page 0 citations

Abstract

A patient is a 78-year-old male. Abdominal ultrasound tomography revealed hepatic tumors. Abdominal computer tomography (CT) revealed a 5.5 cm-in-diameter low enhanced lesion and a 4.0 cm-in-diameter enhanced lesion at S8, and a 1.8 cm-in-diameter enhanced lesion at S5, a 1.4 cm-in-diameter enhanced lesion at S6, which led to a diagnosis of combined hepatocellular carcinoma with intra-hepatic metastasis (IM2) in July 2007. From August to October 2006, he received a hepatic combination therapy with trans-arterial chemotherapy at a low enhanced lesion and trans-arterial embolization (TAE), and radiofrequency ablation therapy (RFA) at enhanced lesions. As of June 2008, this patient is still alive with no recurrence after 8 months from the beginning of this treatment. In conclusion, it might have been effective and suitable to combine multiple therapies to each of the tumor characteristics for mixed hepatocellular carcinoma.

About this research paper

What this paper is about

A patient is a 78-year-old male. Abdominal ultrasound tomography revealed hepatic tumors. Abdominal computer tomography (CT) revealed a 5.5 cm-in-diameter low enhanced lesion and a 4.0 cm-in-diameter enhanced lesion at S8, and a 1.8 cm-in-diameter enhanced lesion at S5, a 1.4 cm-in-diameter enhanced lesion at S6, which led to a diagnosis of combined hepatocellular carcinoma with intra-hepatic metastasis (IM2) in July 2007. From August to October 2006, he received a hepatic combination therapy with trans-arterial chemotherapy at a low enhanced lesion and trans-arterial embolization (TAE), and radiofrequency ablation therapy (RFA) at enhanced lesions. As of June 2008, this patient is still alive with no recurrence after 8 months from the beginning of this treatment. In conclusion, it might have been effective and suitable to combine multiple therapies to each of the tumor characteristics for mixed hepatocellular carcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A patient is a 78-year-old male. Abdominal ultrasound tomography revealed hepatic tumors. Abdominal computer tomography (CT) revealed a 5.5 cm-in-diameter low enhanced lesion and a 4.0 cm-in-diameter enhanced lesion at S8, and a 1.8 cm-in-diameter enhanced lesion at S5, a 1.4 cm-in-diameter enhanced lesion at S6, which led to a diagnosis of combined hepatocellular carcinoma with intra-hepatic metastasis (IM2) in July 2007. From August to October 2006, he received a hepatic combination therapy with trans-arterial chemotherapy at a low enhanced lesion and trans-arterial embolization (TAE), and radiofrequency ablation therapy (RFA) at enhanced lesions. As of June 2008, this patient is still alive with no recurrence after 8 months from the beginning of this treatment. In conclusion, it might have been effective and suitable to combine multiple therapies to each of the tumor characteristics for mixed hepatocellular carcinoma.

Key concepts: Medicine, Lesion, Hepatocellular carcinoma, Arterial Embolization, Radiofrequency ablation, Radiology, Chemotherapy, Metastasis

Related papers

Back to paper searchBrowse research topicsOriginal source
[A case of successful combination therapy with trans-arterial embolization, trans-arterial chemotherapy and radiofrequency ablation therapy]. — Research Paper | ScholarLens